A cost-utility analysis of mindfulness-based cognitive therapy versus cognitive behavioral therapy for major depressive disorder relapse prevention in primary care.
Psychiatry Res February 4, 2026 DOI: 10.1016/j.psychres.2026.116996 (opens in new tab) via PubMed
Summary
AI-generated from the abstractMindfulness-based cognitive therapy is as cost-effective as cognitive behavioral therapy for preventing relapse of major depressive disorder in primary care, with both therapies yielding similar improvements in quality-adjusted life years and total costs over a 12-month follow-up period.
Study at a glance
| Characteristics | Cost-utility analysis Peer reviewed |
|---|---|
| Population | Primary care patients with major depressive disorder |
| Interventions | Mindfulness-based cognitive therapy Cognitive behavioral therapy |
| Duration | 12-month follow-up |
| Key finding | Mindfulness-based cognitive therapy is as cost-effective as cognitive behavioral therapy for relapse prevention in major depressive disorder. |
Abstract
A cost-utility analysis of mindfulness-based cognitive therapy versus cognitive behavioral therapy for major depressive disorder relapse prevention in primary care.